The Fragility Index of Randomized Controlled Trials for Preterm Neonates

BACKGROUND: As a metric to determine the robustness of trial results, the fragility index (FI) is the number indicating how many patients would be required to reverse the significant results. This study aimed to calculate the FI in randomized controlled trials (RCTs) involving premature. METHODS: Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huiyi, Liang, Zhenyu, Meng, Qiong, Huang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124941/
https://www.ncbi.nlm.nih.gov/pubmed/35615631
http://dx.doi.org/10.3389/fped.2022.876366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124941/
https://www.ncbi.nlm.nih.gov/pubmed/35615631
http://dx.doi.org/10.3389/fped.2022.876366

Ejemplares similares